Metatron Health

Botanical species · safety record

Crataegus pinnatifida

The EFSA Compendium of Botanicals holds 3 constituent measurements for Crataegus pinnatifida. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Crataegus pinnatifida Bunge

3Constituent measurements
0Safety records
3Cited sources
281Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 281 licensed products naming Crataegus pinnatifida as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • decoction
  • solid

Source material stated

  • Berry extract
  • Berry/Berries
  • Crataegus pinnatifida
  • Crataegus pinnatifida var. major - Fruit
  • Crataegus pinnatifida, fruit
  • Dried fruit
  • Dried ripe fruit
  • Fruit

What the records describe

Constituents measured

  • Amygdalin1
  • Lignans1
  • Neolignans1

Plant parts

  • Seed2
  • Leaves1

Preparations

  • Solvent extraction3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
LignansLeavesSolvent extraction—UnspecifiedResolve DOI
NeolignansSeedSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
AmygdalinSeedSolvent extraction—Enzyme Immunoassay Tests (EIA)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Cho, A.-Yeon., Shin, Kum-Joo., Chung, Junho., Oh, Sangsuk. A sensitive enzyme immunoassay for amygdalin in food extracts using a recombinant antibody. Journal of food protection, 2008, p. 2048-2052.
  2. Wu, Jiaqi., Peng, Wei., Qin, Rongxin., Zhou, Hong. Crataegus pinnatifida: Chemical Constituents, Pharmacology, and Potential Applications . Molecules, 2014, vol. 19, no. 2, p. 1685-1712. DOI
  3. Huang, Xiao-Xiao., Zhou, Chen-Chen., Li, Ling-Zhi., Li, Fei-Fei., Lou, Li-Li., Li, Dian-Ming., Ikejima, Takshi., Peng, Ying., Song, Shao-Jiang. The cytotoxicity of 8-O-4 ' neolignans from the seeds of Crataegus pinnatifida . Bioorganic & medicinal chemistry letters, 2013, vol. 23, no. 20, p. 5599-5604. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature

Europe PMC

Every record indexed for this species, resolvable and re-runnable.

All species

Substance index

Search and browse every species this world holds under source and hash.

Before anything else

Safety Centre

Interactions, contraindications and the escalation boundary this world does not cross.

In its own terms

Traditions

How the living traditions approach preparation, use and context.